Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Citations received
14
304
2019
25
291
2020
10
105
2021
12
91
2022
8
37
2023
21
52
2024
34
36
2025
20
0
2026
Source: OpenAlex Β· Each yearβs green bar = citations earned by that yearβs papers, counted to date β so recent years look lower simply because their papers havenβt had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category β its quartile can differ by discipline.
Hemoglobinopathies and Related DisordersLymphoma Diagnosis and TreatmentIron Metabolism and DisordersChronic Lymphocytic Leukemia ResearchBlood groups and transfusionAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchViral-associated cancers and disordersChronic Myeloid Leukemia Treatments
Frequently asked questions about Advances in Hematology
Is Advances in Hematology a predatory journal?
PubScope has no integrity flags on record for Advances in Hematology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 74/100. Indexing is a transparency signal, not a guarantee β always confirm fit and policies before submitting.
What is the impact factor of Advances in Hematology?
Advances in Hematology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.439.
Is Advances in Hematology indexed in Scopus and Web of Science?
Advances in Hematology is indexed in Scopus, DOAJ.
What is the aims and scope of Advances in Hematology?